Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 6 of 6 entries
View as:

Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT04042623 Org: User:
Start: 11/27/19 End: 08/01/20 Due: 08/01/21

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04983407 Org: User:
Start: 07/28/21 End: 08/14/23 Due: 08/14/24

Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04729608 Org: User:
Start: 04/22/21 End: 08/04/23 Due: 08/04/24

Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03639246 Org: User:
Start: 12/06/18 End: 12/30/22 Due: 12/30/23

A Phase 1 AVB-S6-500 Safety and Tolerability Study

Phase: N/A Priority: Normal
NCT ID: NCT03401528 Org: User:
Start: 01/31/18 End: 07/31/18 Due: 07/31/19

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04300140 Org: User:
Start: 02/26/21 End: 08/14/23 Due: 08/14/24